A scientist’s rigor.
A leader’s perspective.
A career at the intersection of clinical evidence, scientific innovation, and healthcare leadership.
Connecting science with what comes next.
Dr. Macklin E. Guzmán is a clinical epidemiologist, translational research scientist, and healthcare executive with more than two decades of experience spanning clinical research, clinical program development, scientific innovation, and healthcare quality.
Throughout his career, Dr. Guzmán has played a central role in designing and advancing evidence-based clinical programs, translating emerging scientific knowledge into practical models of care, and guiding healthcare product development and scientific strategy.
Dr. Guzmán brings an interdisciplinary perspective informed by epidemiology, public health, healthcare strategy, and scientific governance. His industry experience includes pharmaceutical scientific engagement and key opinion leader activities, as well as evaluation of emerging therapeutics, clinical technologies, and healthcare products.
He currently serves as Chief Science & Quality Officer at Medi-Weightloss. His broader professional interests encompass translating clinical evidence into practice, advancing healthcare innovation, and strengthening the quality of decisions made across health and life sciences.
Through research, writing, speaking, and select professional collaborations, Dr. Guzmán aims to contribute a practical, independent scientific perspective to the conversations shaping the future of healthcare.
Science, innovation, and leadership.
A multidisciplinary practice shaped by both evidence and its application.
Clinical Epidemiology & Translational Science
Study design, outcomes research, scientific interpretation, evidence synthesis, and real-world application.
Product Development & Scientific Innovation
Scientific evaluation, clinical relevance, product strategy, emerging technologies, and evidence-informed development.
Scientific Leadership & Healthcare Strategy
Quality, scientific governance, cross-disciplinary leadership, and strategic approaches to healthcare improvement.
Pharmaceutical & Industry Scientific Advisory
Scientific exchange, therapeutic evidence, advisory dialogue, and insights spanning clinical practice and industry innovation.
Established specialty: Metabolic health, obesity medicine, and chronic disease management remain important areas of Dr. Guzmán’s research and applied experience.
Leadership beyond the organization.
Professional association governance and collaboration complement a career in scientific and healthcare leadership.
Florida Obesity Society
As a founding board member of the Florida Obesity Society, Dr. Guzmán supports a professional community focused on evidence-based obesity care, education, interdisciplinary collaboration, and advocacy.
View the Society’s board of directors ↗Education, inquiry, and perspective.
Nova Southeastern University
Dr. Kiran C. Patel College of Allopathic MedicineDoctor of Health Science (DHSc)Global Health & Clinical Ethics
Yale University
Yale School of Public HealthMaster of Public Health (MPH)Health Policy & Administration; Epidemiology
Brandeis University
Bachelor of Arts (BA)
University of Michigan
School of Public Health
Summer Enrichment Program (SEP)
Public health in practice.
A global and community perspective
Dr. Guzmán’s scientific perspective is informed by hands-on public health work in international and community settings.
During global health fieldwork in Uganda, he carried out field-based malaria diagnostic microscopy and participated in vaccination outreach and administration, HIV testing and counseling, and infectious disease prevention.
Earlier, through the University of Michigan’s Summer Enrichment Program, he worked with Latino Family Services in Detroit, operating a mobile needle-exchange program and coordinating community health outreach, including mobile pediatric dental services and HIV prevention activities.
These formative experiences continue to inform Dr. Guzmán’s approach to clinical science, healthcare innovation, and the delivery of evidence-based care across diverse populations.
Science is most valuable when it informs better choices.
Explore selected scholarly contributions or connect about speaking, commentary, and appropriate advisory opportunities.